1|Page
Week 8 Final Exam for NR566 / NR-566 (Advanced Pharmacology) 2026–2027
Latest Update | Comprehensive Practice Questions & Answers | Evidence-Based
Medication Management, Clinical Decision-Making, Pharmacotherapeutics,
Prescribing Guidelines & Final Exam Review PDF
NR566 Week 8 Final Exam - Quick Summary
📋 EXAM AT A GLANCE
| Feature | Details |
| Questions | 250 Multiple Choice (ALL randomized, NO subtopics) |
| Format | Scenario-based, clinical decision-making |
| Answers | Indicated with checkmark |
| Rationales | Summarized in italics |
🔑 KEY TOPICS COVERED
| Category | What's Tested |
| Hormone Therapy | SERMs (raloxifene), estrogens, progestins, OCs, androgens |
| Infections | Chlamydia, gonorrhea, BV, herpes, trichomoniasis, syphilis |
| Parkinson's | Levodopa, dopamine agonists, MAO-B, COMT inhibitors, amantadine |
| Alzheimer's | Cholinesterase inhibitors, memantine |
| Migraine | Triptans, propranolol, divalproex, amitriptyline |
| Psychiatry | SSRIs, SNRIs, TCAs, MAOIs, lithium, mood stabilizers, benzodiazepines, antipsychotics |
| BPH | Tamsulosin, silodosin, finasteride (floppy iris syndrome!) |
,2|Page
| Herbals | Ginkgo, echinacea, St. John's Wort, ginger, flaxseed, black cohosh |
⚠️ HIGH-YIELD SAFETY POINTS
- Lithium → Monitor levels, sodium, renal/thyroid; avoid NSAIDs, diuretics
- MAOIs → Avoid tyramine foods (aged cheese, cured meats, Chianti)
- Triptans → Contraindicated in heart disease
- Antipsychotics → EPS, metabolic effects; black box in elderly dementia
- Alpha-blockers → Floppy iris syndrome risk before cataract surgery
💊 DRUG CLASSES TO KNOW
Parkinson's: Levodopa (most effective), Pramipexole (sleep attacks, impulse control), Entacapone (COMT inhibitor)
Alzheimer's: Donepezil, Rivastigmine (patch for PD dementia), Memantine (NMDA antagonist)
Migraine: Sumatriptan (acute), Propranolol (prevention), Divalproex (contraindicated in pregnancy)
Psych: SSRIs (1st line), MAOIs (2nd line), Lithium (bipolar gold standard)
📝 TEST-TAKING TIPS
1. Read scenarios carefully - look for contraindications (pregnancy, heart disease, DVT history)
2. Know 1st line vs 2nd line treatments
3. Monitor parameters - which labs to check before starting
4. Drug interactions - lithium + NSAIDs, MAOI + tyramine, phenytoin + OCs
5. Side effects - pramipexole (impulse control), tamsulosin (floppy iris), SSRIs (hyponatremia)
1. A 65-year-old female with osteoporosis and a history of deep vein thrombosis is seeking treatment. Which medication would
be most appropriate for this patient?
,3|Page
A) Estrogen therapy
B) Raloxifene
C) Alendronate
D) Calcitonin
Rationale: Raloxifene carries a risk of venous thromboembolism and would be contraindicated in a patient with a history of DVT.
Alendronate is a bisphosphonate that does not increase thrombotic risk and is effective for osteoporosis treatment.
2. A postmenopausal woman reports intolerable hot flashes and night sweats. She has a history of breast cancer. Which
medication would be most appropriate?
A) Estradiol patch
B) Femring
C) Raloxifene
D) Medroxyprogesterone
Rationale: Raloxifene is a selective estrogen receptor modulator that provides estrogen benefits without stimulating breast tissue,
making it appropriate for patients with breast cancer history. It effectively treats vasomotor symptoms while reducing breast
cancer risk.
, 4|Page
3. A 52-year-old woman presents with dysfunctional uterine bleeding. What is the recommended course of treatment?
A) Estrogen therapy for 5 days
B) Progestin for 10-14 days
C) Combined oral contraceptives for 21 days
D) Progestin for 5-7 days
Rationale: Dysfunctional uterine bleeding is typically managed with a 10-14 day course of progestin to stabilize the endometrial
lining and control bleeding.
4. A 28-year-old female with amenorrhea is found to have low estrogen levels. What is the appropriate progestin treatment
duration to induce menstrual flow?
A) 3-5 days
B) 5-10 days
C) 10-14 days
D) 14-21 days
Rationale: When estrogen levels are low in amenorrhea, a progestin course of 5-10 days is recommended to induce menstrual
flow by causing withdrawal bleeding.
Week 8 Final Exam for NR566 / NR-566 (Advanced Pharmacology) 2026–2027
Latest Update | Comprehensive Practice Questions & Answers | Evidence-Based
Medication Management, Clinical Decision-Making, Pharmacotherapeutics,
Prescribing Guidelines & Final Exam Review PDF
NR566 Week 8 Final Exam - Quick Summary
📋 EXAM AT A GLANCE
| Feature | Details |
| Questions | 250 Multiple Choice (ALL randomized, NO subtopics) |
| Format | Scenario-based, clinical decision-making |
| Answers | Indicated with checkmark |
| Rationales | Summarized in italics |
🔑 KEY TOPICS COVERED
| Category | What's Tested |
| Hormone Therapy | SERMs (raloxifene), estrogens, progestins, OCs, androgens |
| Infections | Chlamydia, gonorrhea, BV, herpes, trichomoniasis, syphilis |
| Parkinson's | Levodopa, dopamine agonists, MAO-B, COMT inhibitors, amantadine |
| Alzheimer's | Cholinesterase inhibitors, memantine |
| Migraine | Triptans, propranolol, divalproex, amitriptyline |
| Psychiatry | SSRIs, SNRIs, TCAs, MAOIs, lithium, mood stabilizers, benzodiazepines, antipsychotics |
| BPH | Tamsulosin, silodosin, finasteride (floppy iris syndrome!) |
,2|Page
| Herbals | Ginkgo, echinacea, St. John's Wort, ginger, flaxseed, black cohosh |
⚠️ HIGH-YIELD SAFETY POINTS
- Lithium → Monitor levels, sodium, renal/thyroid; avoid NSAIDs, diuretics
- MAOIs → Avoid tyramine foods (aged cheese, cured meats, Chianti)
- Triptans → Contraindicated in heart disease
- Antipsychotics → EPS, metabolic effects; black box in elderly dementia
- Alpha-blockers → Floppy iris syndrome risk before cataract surgery
💊 DRUG CLASSES TO KNOW
Parkinson's: Levodopa (most effective), Pramipexole (sleep attacks, impulse control), Entacapone (COMT inhibitor)
Alzheimer's: Donepezil, Rivastigmine (patch for PD dementia), Memantine (NMDA antagonist)
Migraine: Sumatriptan (acute), Propranolol (prevention), Divalproex (contraindicated in pregnancy)
Psych: SSRIs (1st line), MAOIs (2nd line), Lithium (bipolar gold standard)
📝 TEST-TAKING TIPS
1. Read scenarios carefully - look for contraindications (pregnancy, heart disease, DVT history)
2. Know 1st line vs 2nd line treatments
3. Monitor parameters - which labs to check before starting
4. Drug interactions - lithium + NSAIDs, MAOI + tyramine, phenytoin + OCs
5. Side effects - pramipexole (impulse control), tamsulosin (floppy iris), SSRIs (hyponatremia)
1. A 65-year-old female with osteoporosis and a history of deep vein thrombosis is seeking treatment. Which medication would
be most appropriate for this patient?
,3|Page
A) Estrogen therapy
B) Raloxifene
C) Alendronate
D) Calcitonin
Rationale: Raloxifene carries a risk of venous thromboembolism and would be contraindicated in a patient with a history of DVT.
Alendronate is a bisphosphonate that does not increase thrombotic risk and is effective for osteoporosis treatment.
2. A postmenopausal woman reports intolerable hot flashes and night sweats. She has a history of breast cancer. Which
medication would be most appropriate?
A) Estradiol patch
B) Femring
C) Raloxifene
D) Medroxyprogesterone
Rationale: Raloxifene is a selective estrogen receptor modulator that provides estrogen benefits without stimulating breast tissue,
making it appropriate for patients with breast cancer history. It effectively treats vasomotor symptoms while reducing breast
cancer risk.
, 4|Page
3. A 52-year-old woman presents with dysfunctional uterine bleeding. What is the recommended course of treatment?
A) Estrogen therapy for 5 days
B) Progestin for 10-14 days
C) Combined oral contraceptives for 21 days
D) Progestin for 5-7 days
Rationale: Dysfunctional uterine bleeding is typically managed with a 10-14 day course of progestin to stabilize the endometrial
lining and control bleeding.
4. A 28-year-old female with amenorrhea is found to have low estrogen levels. What is the appropriate progestin treatment
duration to induce menstrual flow?
A) 3-5 days
B) 5-10 days
C) 10-14 days
D) 14-21 days
Rationale: When estrogen levels are low in amenorrhea, a progestin course of 5-10 days is recommended to induce menstrual
flow by causing withdrawal bleeding.
